Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Memancad D Tablet may be taken with or without food, but it is better to take it at a fixed time.
Memancad D Tablet is a combination of two medicines: Donepezil and Memantine which treat Alzheimer’s disease. Donepezil is a cholinesterase inhibitor while Memantine is an NMDA inhibitor. Together, they balance the levels of chemical messengers in the brain and help in the transmission of nerve signals.
Interaction with alcohol is unknown. Please consult your doctor.
WEIGH RISKS VS BENEFITS
Memancad D Tablet may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
No information is available on the use of Memancad D Tablet during lactation. Please consult your doctor.
Memancad D Tablet may cause side effects which could affect your ability to drive.
Memancad D Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Memancad D Tablet may not be needed in these patients. Please consult your doctor.
Memancad D Tablet should be used with caution in patients with liver disease. Dose adjustment of Memancad D Tablet may be needed. Please consult your doctor.
“The following are the results of on-going survey on 1mg.com for Memancad D Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 8th Mar 2017.